Results 61 to 70 of about 6,800,049 (185)
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li +29 more
wiley +1 more source
Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
Cancer is one of the lethal diseases that arise due to the molecular alterations in the cell. One of those alterations associated with cancer corresponds to differential expression of Farnesoid X receptor (FXR), a nuclear receptor regulating bile ...
Sosmitha Girisa +5 more
doaj +1 more source
Abstract Cerebrotendinous xanthomatosis (CTX) is a treatable genetic disorder associated with deficiency of the sterol 27‐hydroxylase enzyme (CYP27A1), important in bile acid synthesis. CTX may present in the newborn period as hepatic jaundice/cholestasis, that can resolve or can progress to fatal liver disease.
Andrea E. DeBarber +3 more
wiley +1 more source
Farnesoid X receptor prevents hyperuricemia via activating ATP‐binding cassette subfamily G member 2
Background The farnesoid X receptor (FXR) is a nuclear receptor that regulates bile acid, lipid, and glucose metabolism. Its role in uric acid (UA) homeostasis, however, remains unclear.
Rui Li +5 more
doaj +1 more source
Bile acids: New regulators of the cardiometabolic crosstalk
Obesity and associated metabolic disorders are major drivers of cardiovascular disease worldwide. Bile acids are now recognized as endocrine signaling molecules that coordinate metabolic, immune, and cardiovascular homeostasis, extending their ...
Stefan Wolf, Marisa Nagler, Elena Osto
doaj +1 more source
Ten new triterpenoid compounds with structure diversity of the C-17 side-chain, including nine tirucallanes, named xylocarpols A⁻E (1⁻5) and agallochols A⁻D (6⁻9), and an apotirucallane, named 25-dehydroxy protoxylogranatin B (10),
Zhong-Ping Jiang +6 more
doaj +1 more source
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide, closely linked to the global rising incidence of obesity and metabolic syndrome. This review synthesizes current evidence on the pathogenesis, gut–liver axis, and multidisciplinary management of MASLD within the ...
Beom Kyung Kim
wiley +1 more source
supplemental data for: Farnesoid X receptor (FXR) activation induces the antioxidant protein metallothionein 1 expression in mouse ...
WEN SU (8063273)
core +1 more source
Farnesoid X receptor induces murine scavenger receptor Class B type I via intron binding.
Farnesoid X receptor (FXR) is a nuclear receptor and a key regulator of liver cholesterol and triglyceride homeostasis. Scavenger receptor class B type I (SR-BI) is critical for reverse cholesterol transport (RCT) by transporting high-density lipoprotein
Guodong Li +7 more
doaj +1 more source
Role of Farnesoid X Receptor in the Pathogenesis of Respiratory Diseases
Farnesoid X receptor (FXR) is a bile acid receptor encoded by the Nr1h4 gene. FXR plays an important role in maintaining the stability of the internal environment and the integrity of many organs, including the liver and intestines. The expression of FXR
Jin-nan Wu +2 more
doaj +1 more source

